葡萄糖凝胶用于无症状低血糖高危新生儿:一项随机临床试验
这项分层随机对照试验纳入629名高危新生儿,其中291名(46%)出现无症状低血糖,分为葡萄糖凝胶组(147名)和对照组(144名)。结论认为葡萄糖凝胶可减少高危无症状低血糖新生儿生后48小时内静脉输液的需求。
要点
- 三个亚组(SGA/IUGR、IDM/LGA、LPT)中葡萄糖凝胶均显著降低治疗失败风险。
- 研究纳入629名高危新生儿,46%出现无症状低血糖,其中葡萄糖凝胶组147名、对照组144名。
核心结论
- 葡萄糖凝胶可减少高危无症状低血糖新生儿生后48小时内静脉输液的需求。
研究设计与样本
- 分层随机对照试验,纳入629名高危新生儿,出现无症状低血糖者291名,分为葡萄糖凝胶组147名和对照组144名。
- 研究人群按小于胎龄儿/宫内生长受限、糖尿病母亲婴儿/大于胎龄儿、晚期早产儿三类分层。
主要发现
- SGA/IUGR亚组风险比0.29(95%CI 0.13-0.67),IDM/LGA亚组0.31(95%CI 0.14-0.66),LPT亚组0.24(95%CI 0.09-0.66)。
关键数值与推荐
- 干预组接受葡萄糖凝胶后母乳喂养,对照组仅母乳喂养。
- 治疗失败定义为需要静脉输液,具体阈值原文未报告。
临床怎么用
- 对于高危无症状低血糖新生儿,可考虑使用葡萄糖凝胶以减少静脉输液和母婴分离。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Hypoglycemia occurs in 5% to 15% of neonates in the first few days. A significant proportion requires admission for intravenous fluids. Dextrose gel may reduce admissions and mother-infant separation. We aimed to study the utility of dextrose gel in reducing the need for intravenous fluids. METHODS: This stratified randomized control trial included at-risk infants with asymptomatic hypoglycemia. Study populations were stratified into 3 categories: small for gestational age (SGA) and intrauterine growth-restriction (IUGR), infants of diabetic mothers (IDM) and large for gestational age (LGA), and late preterm (LPT) neonates. Intervention group received dextrose gel followed by breastfeeding, and the control group (CG) received only breastfeeding. RESULTS: Among 629 at-risk infants, 291 (46%) developed asymptomatic hypoglycemia; 147 (50.4%) in the dextrose gel group (DGG) and 144 (49.6%) in CG. There were 97, 98, and 96 infants in SGA/IUGR, IDM/LGA, and LPT categories, respectively. Treatment failure in the DGG was 17 (11.5%) compared to 58 (40.2%) in CG, with a risk ratio of 0.28 (95% confidence interval [CI]: 0.17-0.46; P < .001). Treatment failure was significantly less in DGG in all 3 categories: SGA/IUGR, IDM/LGA, and LPT with a risk ratio of 0.29 (95% CI:0.13-0.67), 0.31 (95% CI:0.14-0.66) and 0.24 (95% CI:0.09-0.66), respectively. CONCLUSIONS: Dextrose gel reduces the need for intravenous fluids in at-risk neonates with asymptomatic hypoglycemia in the first 48 hours of life.
引用
- Gupta K, Amboiram P, Balakrishnan U, et al. Dextrose Gel for Neonates at Risk With Asymptomatic Hypoglycemia: A Randomized Clinical Trial. Pediatrics. 2022. PMID: 35582897. doi:10.1542/peds.2021-050733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。